Advertisement
Screener

Acorda Therapeutics, Inc. Variable Lease, Cost

Acorda Therapeutics, Inc. Variable Lease, Cost

Acorda Therapeutics, Inc. reported Variable Lease, Cost of $94.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.

Discontinued › Expense Statement › Operating Expenses

us-gaap:VariableLeaseCost · last filed 2024-05-14

  • Acorda Therapeutics, Inc. variable lease, cost for the quarter ending 2024-03-31 was $94.00K, a 6.00% decline year-over-year.
  • Acorda Therapeutics, Inc. variable lease, cost for the quarter ending 2023-12-31 was $17.00K, a 62.22% decline year-over-year.
  • Acorda Therapeutics, Inc. variable lease, cost for the quarter ending 2023-09-30 was $205.00K, a 55.30% increase year-over-year.
  • Acorda Therapeutics, Inc. variable lease, cost for the quarter ending 2023-06-30 was $103.00K, a 89.36% decline year-over-year.
  • Acorda Therapeutics, Inc. variable lease, cost for fiscal 2023 was $426.00K, a 78.75% decline from fiscal 2022.
  • Acorda Therapeutics, Inc. variable lease, cost for fiscal 2022 was $2.00M, a 51.76% decline from fiscal 2021.
  • Acorda Therapeutics, Inc. variable lease, cost for fiscal 2021 was $4.16M, a 14.30% increase from fiscal 2020.
  • Acorda Therapeutics, Inc. variable lease, cost for fiscal 2020 was $3.64M, a 20.70% decline from fiscal 2019.
Period endVariable Lease, Cost 3 monthVariable Lease, Cost 6 monthVariable Lease, Cost 9 monthVariable Lease, Cost 12 month
2024-03-31$94.00K
10-Q · filed 2024-05-14
$111.00K
derived: sum of 2 quarters · filed 2024-05-14
$316.00K
derived: sum of 3 quarters · filed 2024-05-14
$419.00K
derived: sum of 4 quarters · filed 2024-05-14
2023-12-31$17.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$222.00K
derived: sum of 2 quarters · filed 2024-04-01
$325.00K
derived: sum of 3 quarters · filed 2024-04-01
$426.00K
10-K · filed 2024-04-01
2023-09-30$205.00K
10-Q · filed 2023-11-14
$308.00K
derived: sum of 2 quarters · filed 2023-11-14
$409.00K
10-Q · filed 2023-11-14
$453.00K
derived: sum of 4 quarters · filed 2024-05-14
2023-06-30$103.00K
10-Q · filed 2023-08-09
$203.00K
10-Q · filed 2023-08-09
$248.00K
derived: sum of 3 quarters · filed 2024-05-14
$380.00K
derived: sum of 4 quarters · filed 2024-05-14
2023-03-31$100.00K
10-Q · filed 2024-05-14
$145.00K
derived: sum of 2 quarters · filed 2024-05-14
$277.00K
derived: sum of 3 quarters · filed 2024-05-14
$1.25M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$45.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$177.00K
derived: sum of 2 quarters · filed 2024-04-01
$1.15M
derived: sum of 3 quarters · filed 2024-04-01
$2.00M
10-K · filed 2024-04-01
2022-09-30$132.00K
10-Q · filed 2023-11-14
$1.10M
derived: sum of 2 quarters · filed 2023-11-14
$1.96M
10-Q · filed 2023-11-14
$2.83M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$968.00K
10-Q · filed 2023-08-09
$1.83M
10-Q · filed 2023-08-09
$2.70M
derived: sum of 3 quarters · filed 2023-08-09
$3.65M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$860.00K
10-Q · filed 2023-05-11
$1.73M
derived: sum of 2 quarters · filed 2023-05-11
$2.68M
derived: sum of 3 quarters · filed 2023-05-11
$3.66M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$873.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15
$1.82M
derived: sum of 2 quarters · filed 2023-03-15
$2.80M
derived: sum of 3 quarters · filed 2023-03-15
$4.16M
10-K · filed 2023-03-15
2021-09-30$948.00K
10-Q · filed 2022-11-14
$1.93M
derived: sum of 2 quarters · filed 2022-11-14
$3.28M
10-Q · filed 2022-11-14
$4.23M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$979.00K
10-Q · filed 2022-08-09
$2.33M
10-Q · filed 2022-08-09
$3.28M
derived: sum of 3 quarters · filed 2022-08-09
$4.34M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$1.36M
10-Q · filed 2022-05-13
$2.31M
derived: sum of 2 quarters · filed 2022-05-13
$3.36M
derived: sum of 3 quarters · filed 2022-05-13
$4.06M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$949.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18
$2.00M
derived: sum of 2 quarters · filed 2022-03-18
$2.71M
derived: sum of 3 quarters · filed 2022-03-18
$3.64M
10-K · filed 2022-03-18
2020-09-30$1.05M
10-Q · filed 2021-11-12
$1.76M
derived: sum of 2 quarters · filed 2021-11-12
$2.69M
10-Q · filed 2021-11-12
$3.73M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$704.00K
10-Q · filed 2021-08-12
$1.64M
10-Q · filed 2021-08-12
$2.68M
derived: sum of 3 quarters · filed 2021-08-12
$3.80M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$932.00K
10-Q · filed 2021-05-12
$1.97M
derived: sum of 2 quarters · filed 2021-05-12
$3.09M
derived: sum of 3 quarters · filed 2021-05-12
$4.85M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$1.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16
$2.16M
derived: sum of 2 quarters · filed 2021-03-16
$3.92M
derived: sum of 3 quarters · filed 2021-03-16
$4.58M
10-K · filed 2021-03-16
2019-09-30$1.12M
10-Q · filed 2020-11-06
$2.88M
derived: sum of 2 quarters · filed 2020-11-06
$3.54M
10-Q · filed 2020-11-06
2019-06-30$1.76M
10-Q · filed 2020-08-07
$2.42M
10-Q · filed 2020-08-07
2019-03-31$664.00K
10-Q · filed 2020-05-08